Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001470831-26-000174

Chief Accounting Officer gave up 3,268 shares (to pay taxes)

  • Chief Accounting Officer acquired 56,980 shares (grant or award)
  • Chief Accounting Officer acquired 9,420 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Mossler Mark · Chief Accounting Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-13 Grant or award : show line 1 in the form +56,980 75,184 D
2026-02-14 Exercise or conversion : show line 2 in the form +9,420 75,184 D
2026-02-14 Shares withheld for taxes : show line 3 in the form −3,268 $1.89 $6,177 71,916 D
Loading xslF345X05/wk-form4_1771452272.xml…